Exercise News and Research

Latest Exercise News and Research

Debilitating muscle weakness can linger long after hospital discharge

After decades of focusing on the management of respiratory failure, circulatory shock and severe infections that lead to extended stays in hospital intensive care units, critical care researchers are increasingly turning attention to what they believe is a treatable complication developed by many who spend days or weeks confined to an ICU bed: debilitating muscle weakness that can linger long after hospital discharge.

28 Oct 2009

ESPRIT project to improve performance of British athletes on world stage

Scientists are developing a range of miniaturised wearable and track-side sensors, computer modelling tools and smart training devices to help British athletes improve their performance on the world stage, as part of a new -8.5 million project that will be officially launched tomorrow (28 October 2009).

28 Oct 2009

Online weight management support for overweight teen girls and mothers

Professionals from the entertainment industry have teamed with leaders in obesity treatment to create the first web destinations that offer affordable and accessible weight management support to overweight teen girls and their mothers.

28 Oct 2009

Tips for affording expensive medication

You've lost your prescription insurance benefits because of unemployment; you don't have the extra money you once did for the co-pay; you have an expensive medication that isn't covered. Unfortunately, this is the current situation for many Americans. Carriann Richey, director of outreach and assistant professor of pharmacy practice for Butler University's College of Pharmacy and Health Sciences, says while affording medications in today's economy may be more difficult than ever before, there are options out there that can help.

28 Oct 2009

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.

28 Oct 2009

Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.

28 Oct 2009

NovaDel and Mist Acquisition enter into licensing agreement to manufacture and commercialize NitroMist

NovaDel Pharma Inc., has entered into a licensing agreement with privately-held Mist Acquisition, LLC to manufacture and commercialize the NitroMist® lingual spray version of nitroglycerine, a widely-prescribed and leading short-acting nitrate for the treatment of angina pectoris.

28 Oct 2009

Internet-based diet and exercise program shows promise in lowering healthcare costs

Researchers from Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH) have shown that an employer-sponsored, internet-based diet and exercise program shows promise as a low-cost benefit to lower healthcare costs for those at higher risk for above-average costs and healthcare utilization such as cardiac, hyperlipidemia, hypertension or diabetes patients.

28 Oct 2009

Researchers find healthy dose of exercise good for lymphoma patients receiving chemotherapy

A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.

28 Oct 2009

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

The discovery of a multi-level arteriovenous malformation (AVM) in the thoracic epidural space can now bring relief to potentially thousands of suffers of chronic thoracic pain and progressive myelopothy. Identified as thoracic epidural arteriovenous malformation (T.E.A.M.), this particular AMV primarily affects younger women ages 20 to 40.

27 Oct 2009

Netpulse raises funds for development of its interactive entertainment platform

Netpulse, the only interactive media platform for fitness centers and active lifestyle consumers, announced today that it has secured $3.1 million in Series A funding led by Javelin Venture Partners with participation from DFJ Frontier.

27 Oct 2009

Even one cigarette has serious adverse effects on young adults, says researcher

Even one cigarette has serious adverse effects on young adults, according to research presented by Dr. Stella Daskalopoulou at the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2009

Inverness Medical Innovations announces its financial results for the third-quarter

Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced its financial results for the quarter ended September 30, 2009.

27 Oct 2009

Benchmark Electronics announces fiscal 2009 third-quarter results

Benchmark Electronics, Inc. (NYSE: BHE), a leading contract manufacturing provider, announced sales of $510 million for the quarter ended September 30, 2009, compared to $642 million for the same quarter in the prior year. The Company reported third quarter net income of $16 million, or $0.25 per diluted share. In the comparable period of 2008, net income was $24 million, or $0.35 per diluted share.

27 Oct 2009

Smoking one cigarette can increase artery stiffness by 25% in young adults

27 Oct 2009

One in five young teens has high blood pressure; elevated cholesterol levels increasing at alarming rate

A seven-year ongoing study examining over 20,000 Canadian grade 9 students shows most already have at least one major risk factor for heart disease and stroke, Dr. Brian McCrindle told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2009

LX211 may become the first approved oral treatment for modifying the course of uveitis

An experimental drug, LX211 (LUVENIQ - oral voclosporin), may become the first approved oral treatment capable of modifying the course of uveitis, a group of serious eye conditions inevitably associated with either severe vision loss or substantial morbidity from steroid use.

27 Oct 2009

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from an open-label extension study evaluating the long-term safety and efficacy of CIMZIA® (certolizumab pegol) in moderate to severe Crohn's disease patients demonstrate that 82 percent of patients actively treated with CIMZIA - the only PEGylated anti-TNF-alpha (Tumor Necrosis Factor alpha) - remained in long-term remission without dose escalation up to 3.5 years.

27 Oct 2009

Genetic mutations cause for SIDS and SUDS

Scientists and clinicians at the Montefiore-Einstein Center for Cardiogenetics have teamed up and found that genetic mutations leading to Long QT Syndrome (LQTS) could be causing electrical malfunctioning of the heart resulting in the mysterious deaths more commonly known as Sudden Infant Death Syndrome (SIDS) and Sudden Unexplained Death Syndrome (SUDS) in people older than 12 months of age.

27 Oct 2009

Status of the pending FDA submission of Lifeline Biotechnologies' First Warning System reported

Lifeline Biotechnologies, Inc. today reported on the status of the pending FDA submission of its First Warning System™, filed in late July 2009.

27 Oct 2009

Exercise News and Research

Latest Exercise News and Research

Debilitating muscle weakness can linger long after hospital discharge

ESPRIT project to improve performance of British athletes on world stage

Online weight management support for overweight teen girls and mothers

Tips for affording expensive medication

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

NovaDel and Mist Acquisition enter into licensing agreement to manufacture and commercialize NitroMist

Internet-based diet and exercise program shows promise in lowering healthcare costs

Researchers find healthy dose of exercise good for lymphoma patients receiving chemotherapy

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

Netpulse raises funds for development of its interactive entertainment platform

Even one cigarette has serious adverse effects on young adults, says researcher

Inverness Medical Innovations announces its financial results for the third-quarter

Benchmark Electronics announces fiscal 2009 third-quarter results

Smoking one cigarette can increase artery stiffness by 25% in young adults

One in five young teens has high blood pressure; elevated cholesterol levels increasing at alarming rate

LX211 may become the first approved oral treatment for modifying the course of uveitis

New data from efficacy study of CIMZIA in Crohn's disease patients presented

Genetic mutations cause for SIDS and SUDS

Status of the pending FDA submission of Lifeline Biotechnologies' First Warning System reported

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Exercise News and Research

Latest Exercise News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in